Home  |  About JAPTR |  Editorial board  |  Search |  Ahead of print  |  Current issue  |  Archives |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |Login 
Users Online: 305   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
     

    Article Cited by others

SHORT COMMUNICATION

A simple Ultraviolet spectrophotometric method for the determination of etoricoxib in dosage formulations

Singh Shipra, Mishra Amrita, Verma Anurag, Ghosh Ashoke K, Mishra Arun K

Year : 2012| Volume: 3| Issue : 4 | Page no: 237-240

   This article has been cited by
 
1 A Critical Review on Analytical Methods for Recently Approved FDC Drugs: Pregabalin and Etoricoxib
Janvi Shah,Rajendra Kotadiya
Critical Reviews in Analytical Chemistry. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
2 TLC-Densitometric Determination of Five Coxibs in Pharmaceutical Preparations
Pawel Gumulka,Monika Dabrowska,Malgorzata Starek
Processes. 2020; 8(5): 620
[Pubmed]  [Google Scholar] [DOI]
3

Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers

Enas El-Maghawry,Mina I Tadros,Seham A El-Kheshen,Ahmed Abd-Elbary
International Journal of Nanomedicine. 2020; Volume 15: 3965
[Pubmed]  [Google Scholar] [DOI]
4 Enhanced Release Kinetics and Stability of Resveratrol Loaded Self Nanoemulsifying Delivery Systems Developed using Experimental Design
Monika Sharma,Rajeev Garg,Satish Sardana
Current Nanomedicine. 2019; 9(2): 128
[Pubmed]  [Google Scholar] [DOI]
5 Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets
Madiha Maboos,Rabia Ismail Yousuf,Muhammad Harris Shoaib,Iqbal Nasiri,Tazeen Hussain,Hafiza Fouzia Ahmed,Wajiha Iffat
Lipids in Health and Disease. 2018; 17(1)
[Pubmed]  [Google Scholar] [DOI]
6 Fabrication of paper-based analytical devices optimized by central composite design
Vahid Hamedpour,Riccardo Leardi,Koji Suzuki,Daniel Citterio
The Analyst. 2018;
[Pubmed]  [Google Scholar] [DOI]
7 Anti-Hypertensive Action of Fenofibrate via UCP2 Upregulation Mediated by PPAR Activation in Baroreflex Afferent Pathway
Jian Guan,Miao Zhao,Chao He,Xue Li,Ying Li,Jie Sun,Wei Wang,Ya-Li Cui,Qing Zhang,Bai-Yan Li,Guo-Fen Qiao
Neuroscience Bulletin. 2018;
[Pubmed]  [Google Scholar] [DOI]
8 Artificial neural networks as alternative tool for minimizing error predictions in manufacturing ultradeformable nanoliposome formulations
José M. León Blanco,Pedro L. González-R,Carmen Martina Arroyo García,María José Cózar-Bernal,Marcos Calle Suárez,David Canca Ortiz,Antonio María Rabasco Álvarez,María Luisa González Rodríguez
Drug Development and Industrial Pharmacy. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
9 Optimization & design of isradipine loaded solid lipid nanobioparticles using rutin by Taguchi methodology
Vikash Kumar,Rajeev Kharb,Hema Chaudhary
International Journal of Biological Macromolecules. 2016; 92: 338
[Pubmed]  [Google Scholar] [DOI]
10 Intravenous administration of trans-resveratrol-loaded TPGS-coated solid lipid nanoparticles for prolonged systemic circulation, passive brain targeting and improved in vitro cytotoxicity against C6 glioma cell lines
Mahalingam Rajamanickam Vijayakumar,Lakshmi Kumari,Krishna Kumar Patel,Parameswara Rao Vuddanda,Kiran Yellappa Vajanthri,Sanjeev Kumar Mahto,Sanjay Singh
RSC Adv.. 2016; 6(55): 50336
[Pubmed]  [Google Scholar] [DOI]
11 Resveratrol loaded PLGA:d-a-tocopheryl polyethylene glycol 1000 succinate blend nanoparticles for brain cancer therapy
Mahalingam Rajamanickam Vijayakumar,Ramoji Kosuru,Sanjay Kumar Singh,Chandra Bhushan Prasad,Gopeshwar Narayan,Madaswamy S. Muthu,Sanjay Singh
RSC Adv.. 2016; 6(78): 74254
[Pubmed]  [Google Scholar] [DOI]
12 Development and Validation of a HPLC Method Using a Monolithic Column for Quantification oftrans-Resveratrol in Lipid Nanoparticles for Intestinal Permeability Studies
Ana Rute Neves,Salette Reis,Marcela A. Segundo
Journal of Agricultural and Food Chemistry. 2015; 63(12): 3114
[Pubmed]  [Google Scholar] [DOI]
13 Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics andin situsingle pass intestinal perfusion (SPIP) studies
Gurinder Singh,Roopa S. Pai
Drug Delivery. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
14 In vivo pharmacokinetic applicability of a simple and validated HPLC method for orally administered trans-resveratrol loaded polymeric nanoparticles to rats
Gurinder Singh,Roopa S. Pai,Vinay Pandit
Journal of Pharmaceutical Investigation. 2014; 44(2): 69
[Pubmed]  [Google Scholar] [DOI]
15 Optimized PLGA nanoparticle platform for orally dosedtrans-resveratrol with enhanced bioavailability potential
Gurinder Singh,Roopa S Pai
Expert Opinion on Drug Delivery. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
16 Optimized self-nanoemulsifying drug delivery system of atazanavir with enhanced oral bioavailability:in vitro/in vivocharacterization
Gurinder Singh,Roopa S Pai
Expert Opinion on Drug Delivery. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
17 In vitro drug release and ex vivo percutaneous absorption of resveratrol cream using HPLC with zirconized silica stationary phase
Hudson Caetano Polonini,Carina de Almeida Bastos,Marcone Augusto Leal de Oliveira,Carla Grazieli Azevedo da Silva,Carol Hollingworth Collins,Marcos Antônio Fernandes Brandão,Nádia Rezende Barbosa Raposo
Journal of Chromatography B. 2014; 947-948: 23
[Pubmed]  [Google Scholar] [DOI]
18 Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization andin vitro/in vivoappraisal
Gurinder Singh,Roopa S Pai
Drug Delivery. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
19 Pharmacokinetics andin vivobiodistribution of optimized PLGA nanoparticulate drug delivery system for controlled release of emtricitabine
Gurinder Singh,Roopa S Pai
Drug Delivery. 2013; : 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article